Faster And Cheaper: Similis Bio Aims To Enhance Biosimilar Development
Intends Deal With Blau Farmaceutica To Be ‘First Of Many’ Parallel Partnerships
Similis believes that through multiple partnerships it can help bring biosimilars to market more quickly and cost-effectively • Source: Shutterstock